Loading, please wait...
- Operating System: Windows, Mac OS and Linux
- Internet Browser: Internet Explorer 7.0 or higher; Mozilla Firefox 3.0 or higher; Google Chrome
- Computer Speakers or headphones connected to your computer
- Broadband Internet Connection: Cable, High-speed DSL or T1
- Monitor Screen Resolution: 320x480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint and HTML
Fee
CE Hours
CE Units
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Co-Sponsor(s)
Requirements for CE Credit
Management of Ventricular Tachycardia in the Emergency Department
- Recognize different etiologies and forms of ventricular tachycardia (VT)
- Analyze different pharmacological options for treating VT
Speaker(s)/Author(s)
|
Lance Ray, PharmD, BCPS
|
Activity Number
0062-9999-22-049-H01-P
CE Hours
'If You Ain't First, You're Last': Adenosine Vs. Calcium Channel Blockers for Supraventricular Tachycardia (SVT)
- Review current guideline recommendations for the treatment of paroxysmal supraventricular tachycardia (pSVT)
- Recognize why adenosine may no longer be the only first-line pharmacologic therapy
- Appraise the current available evidence for calcium channel blockers (CCB) in pSVT
- Discuss scenarios when not to use either agent
Speaker(s)/Author(s)
|
Nicholas Servati, PharmD, BCCP
|
Activity Number
0062-9999-22-050-H01-P
CE Hours
Common Pitfalls in ED Antimicrobial Prescribing
- Summarize the value of a local emergency department antibiogram
- Recognize potential short falls of select antibiotics, and assess potential alternatives for community acquired pneumonia, urinary tract infections, and skin and soft tissue infections
- Recognize opportunities to shorten antibiotic therapy duration for select infectious processes
Speaker(s)/Author(s)
|
Mark Anthony Mixon, PharmD, BCPS, BCIDP, BCCCP
|
Activity Number
0062-9999-22-051-H01-P
CE Hours
Stirred, Not Shaken: Utility of Viscoelastic Testing for Monitoring Coagulation in Critically Ill Populations
- Discuss coagulation and risk factors for coagulopathy
- Describe the use of viscoelastic tests in critically ill emergency department (ED) patients
Speaker(s)/Author(s)
|
Megan A Rech, PharmD, MS, BCCCP, FCCM
|
Activity Number
0062-9999-22-052-H01-P
CE Hours
Talking Heads - "This must be the plase"
- Assess systemic fibrinolytic strategies for acute ischemic stroke
- Compare pharmacologic differences between alteplase and tenecteplase
- Evaluate literature supporting current guideline recommendations for both alteplase and tenecteplase
Speaker(s)/Author(s)
|
James Priano, PharmD, BCPS
|
Activity Number
0062-9999-22-053-H01-P
CE Hours
Thrombolytics in Cardiac Arrest
- Discuss the epidemiology, pathophysiology, and risk stratification of pulmonary embolisms (PE)
- Review bedside tools and strategies used to narrow the presentation differential
- Examine treatment options for the management of massive PE
Speaker(s)/Author(s)
|
Terren Trott, MD
|
Activity Number
0062-9999-22-054-H01-P
CE Hours
The superiority of F(ab')2 compared to FabAV; or vice versa?
- Describe the important differences between antivenom products
- Debate whether Copperheads should be considered in a different category to other pit vipers for the purposes of antivenom treatment and outcome measurement
- Critique the definition of "initial control"
Speaker(s)/Author(s)
|
Craig Cocchio, PharmD, BCPS, DABAT
|
Activity Number
0062-9999-22-055-H01-P
CE Hours
Alternative Dosing Strategies for N-Acetylcysteine in Acetaminophen Overdose
- Explain the rationale for the original intravenous NAC dosing regimen in the UK, the original oral regimen using the FDA approved inhalational product in the US and current practices utilizing varying routes, numbers of intravenous bags or doses or dosing rates
- Outline risk factors not yet considered in these regimens that may explain and or be used to modify the regimen in an individualized patient at initiation or during therapy
- Justify an individualized regimen choice from current practices on the basis of location, supply, patient prognosis, risk factors and patient response
Speaker(s)/Author(s)
|
Frank P. Paloucek, PharmD, FASHP, FAACT, DPLA, DABAT
|
Activity Number
0062-9999-22-056-H01-P
CE Hours
Skin and Soft Tissue Infection Treatment Utilizing Long Acting Antibiotics
- Discuss the key differences in using lipoglycopeptides compared to traditional therapies for acute bacterial skin and skin structure infections (ABSSSI)
- Determine the clinical and financial impacts of using a lipoglycopeptide protocol in the Emergency Department
Speaker(s)/Author(s)
|
Abby M. Bailey, PharmD, BCCCP
|
Activity Number
0062-9999-22-057-H01-P
CE Hours
Hypertonic Saline Vs Mannitol
- Describe the pathological processes underlying the formation of cerebral edema
- Compare the available literature supporting the use of hypertonic saline and mannitol in the management of cerebral edema
- Identify important considerations for implementing osmotherapy in the emergency department
Speaker(s)/Author(s)
|
Kyle Weant, PharmD, BCPS, BCCCP, BCEMP, FCCP
|
Activity Number
0062-9999-22-058-H01-P
CE Hours
Opioid-Sparing Therapies in the ED
- Identify non-opioid analgesic modalities available in the Emergency Department (ED)
- Evaluate advantages and disadvantages of commonly used non-opioid therapies in the ED based on the up-to-date evidence
Speaker(s)/Author(s)
|
Sergey M. Motov, MD FAAEM
|
Activity Number
0062-9999-22-059-H08-P
CE Hours
Novel Approaches to Buprenorphine Utilization in the ED
- Describe buprenorphine induction strategies in the Emergency Department (ED)
- Summarize monitoring and dose titration of buprenorphine
- Discuss transitions of care for the patients initiated on buprenorphine in the ED
Speaker(s)/Author(s)
|
David E. Zimmerman, PharmD, BCCCP
|
Activity Number
0062-9999-22-060-H08-P
CE Hours
Tranexamic Acid in the Trauma Patient
- Review the etiology and pathophysiology of trauma induced coagulopathy
- Recall the pharmacology of tranexamic acid (TXA)
- Analyze the literature regarding the use of TXA in trauma patients
Speaker(s)/Author(s)
|
Ruben Santiago, PharmD
|
Activity Number
0062-9999-22-061-H01-P
CE Hours
The Pharmacologic Approach to Severe Alcohol Withdrawal: A Focus on Phenobarbital vs Benzodiazepines
- Review pathophysiology and assessment of acute alcohol withdrawal syndrome
- Discuss the pharmacology and pharmacokinetics of common medications used in alcohol withdrawal
- Analyze the clinical literature regarding management of alcohol withdrawal using phenobarbital
Speaker(s)/Author(s)
|
Jimmy L. Pruitt III, PharmD, BCPS
|
Activity Number
0062-9999-22-062-H01-P
CE Hours
Anticoagulation Reversal Strategies in the Bleeding Patient
- Interpret practical laboratory values helpful for evaluating the degree of anticoagulation in the acute care setting
- Describe the clinical pharmacology of available anticoagulants and reversal agents
- Evaluate potential agents and strategies for reversal of anticoagulants including warfarin, direct thrombin inhibitors, and direct factor Xa inhibitors
Speaker(s)/Author(s)
|
Bryan D. Hayes, PharmD, DABAT, FAACT, FASHP
|
Activity Number
0062-9999-22-063-H01-P
CE Hours
Sedation of the Aggressive Patient in the Emergency Department
- Describe the main causes of acute agitation in the Emergency Department (ED)
- Discuss the various treatment options for the acutely agitated patient in ED
- Describe the onset of action and adverse effects of the chemical sedatives used for acute agitation
Speaker(s)/Author(s)
|
Amy Thomson, MSHP
|
Activity Number
0062-9999-22-064-H01-P